Evidence map›Paper›PMID 35705748›Full record

ArticleArchives of microbiology2022

Reactive oxygen species accumulation is synchronised with growth inhibition of temperature-sensitive recAts polA Escherichia coli.

Akihiro Kaidow, Noriko Ishii, Sinngo Suzuki, Takashi Shiina, Hirokazu Kasahara

Open access · hybridAbstract read
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Genomic andFrontiers in microbiology · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Akihiro KaidowDepartment of Biology, School of Biology, Tokai University, Sapporo, 005-8601, Japan. akaidow@tsc.u-tokai.ac.jp.ORCID http://orcid.org/0000-0003-3404-6253
Noriko IshiiDepartment of Bioscience and Technology, School of Biology, Tokai University, Sapporo, 005-8601, Japan.
Sinngo SuzukiDepartment of Molecular Medicine, School of Medicine, Tokai University, Isehara, 259-1193, Japan.
Takashi ShiinaDepartment of Molecular Medicine, School of Medicine, Tokai University, Isehara, 259-1193, Japan.
Hirokazu KasaharaDepartment of Bioscience and Technology, School of Biology, Tokai University, Sapporo, 005-8601, Japan.
Tokai University · JP

Funding

Ministry of education (JP) 11146218
6 · The paper itself

Abstract

When combined with recombinase defects, chromosome breakage and double-strand break repair deficiencies render cells inviable. However, cells are viable when an SOS response occurs in recAts polA cells in Escherichia coli. Here, we aimed to elucidate the underlying mechanisms of this process. Transposon mutagenesis revealed that the hslO gene, a redox chaperone Hsp33 involved in reactive oxidative species (ROS) metabolism, was required for the suppression of recAts polA lethality at a restricted temperature. Recently, it has been reported that lethal treatments trigger ROS accumulation. We also found that recAts polA cells accumulated ROS at the restricted temperature. A catalase addition to the medium alleviates the temperature sensitivity of recAts polA cells and decreases ROS accumulation. These results suggest that the SOS response and hslO manage oxidative insult to an acceptable level in cells with oxidative damage and rescue cell growth. Overall, ROS might regulate several cellular processes.

Indexed as

Escherichia coliEscherichia coli ProteinsDNA RepairHeat-Shock ProteinsMutagenesisReactive Oxygen SpeciesTemperatureEscherichia coli ProteinsHeat-Shock ProteinsHSP33 protein, E coliReactive Oxygen SpeciesHsp33Oxidative damagerecAts polA lethalityRedox molecular chaperonROSSOS response

Identifiers

PMID35705748
PMCPMC9200703
OpenAlexW4283010758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.